Edgewise Therapeutics Ownership 2024 | Who Owns Edgewise Therapeutics Now?
Institutional Ownership
5.59%
Insider Ownership
0.47%
Retail Ownership
93.94%
Institutional Holders
42.00
Edgewise Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 17.15% | 5.38% | 15,021,721 | - | - | 270,541,195 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 10.17% | 2.12% | 8,909,091 | - | - | 160,452,729 | Jun 30, 2024 |
| NOVO HOLDINGS A/S | 7.25% | 6.63% | 6,344,430 | 6,344,430 | 100.00% | 114,263,184 | Jun 30, 2024 |
| BLACKROCK INC. | 6.87% | 0.00% | 6,015,711 | 848,705 | 16.43% | 108,342,955 | Jun 30, 2024 |
| BAKER BROS. ADVISORS LP | 6.67% | 1.34% | 5,840,059 | - | - | 105,179,463 | Jun 30, 2024 |
| FMR LLC | 5.46% | 0.01% | 4,780,563 | -1,585,161 | -24.90% | 86,097,933 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.15% | 0.00% | 4,508,166 | 490,733 | 12.22% | 81,192,069 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 4.26% | 3.14% | 3,731,067 | 427,500 | 12.94% | 67,196,517 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 3.43% | 3.13% | 3,006,534 | - | - | 54,147,677 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3.28% | 0.86% | 2,874,586 | - | - | 51,771,294 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 2.98% | 0.03% | 2,607,299 | 801,987 | 44.42% | 46,928,267 | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 2.66% | 1.60% | 2,325,449 | -120,924 | -4.94% | 41,881,336 | Jun 30, 2024 |
| TCG CROSSOVER MANAGEMENT, LLC | 2.60% | 4.27% | 2,272,728 | - | - | 40,931,831 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 2.12% | 0.79% | 1,856,417 | -463,229 | -19.97% | 33,434,070 | Jun 30, 2024 |
| VR ADVISER, LLC | 2.08% | 2.09% | 1,818,182 | - | - | 32,745,458 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.91% | 0.00% | 1,672,653 | 302,756 | 22.10% | 30,130,154 | Jun 30, 2024 |
| STATE STREET CORP | 1.90% | 0.00% | 1,665,095 | 453,619 | 37.44% | 29,988,361,000 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.85% | 0.00% | 1,622,741 | -125,103 | -7.16% | 29,225,566 | Jun 30, 2024 |
| NEW LEAF VENTURE PARTNERS, L.L.C. | 1.77% | 34.03% | 1,553,661 | - | - | 27,981,435 | Jun 30, 2024 |
| VIKING GLOBAL INVESTORS LP | 1.69% | 0.10% | 1,481,146 | -1,858,000 | -55.64% | 26,675,439 | Jun 30, 2024 |
Edgewise Therapeutics's largest institutional shareholder is ORBIMED ADVISORS LLC, holding 17.15% of the company's total share outstanding, currently valued at $270.54M. The top 10 institutional shareholders own together 69.70% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NEW LEAF VENTURE PARTNERS, L.L.C. | 1.77% | 34.03% | 1,553,661 | - | - | 27,981,435 | Jun 30, 2024 |
| NOVO HOLDINGS A/S | 7.25% | 6.63% | 6,344,430 | 6,344,430 | 100.00% | 114,263,184 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 17.15% | 5.38% | 15,021,721 | - | - | 270,541,195 | Jun 30, 2024 |
| TCG CROSSOVER MANAGEMENT, LLC | 2.60% | 4.27% | 2,272,728 | - | - | 40,931,831 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 4.26% | 3.14% | 3,731,067 | 427,500 | 12.94% | 67,196,517 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 3.43% | 3.13% | 3,006,534 | - | - | 54,147,677 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 0.66% | 2.39% | 580,000 | -85,000 | -12.78% | 10,445,800 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 10.17% | 2.12% | 8,909,091 | - | - | 160,452,729 | Jun 30, 2024 |
| VR ADVISER, LLC | 2.08% | 2.09% | 1,818,182 | - | - | 32,745,458 | Jun 30, 2024 |
| BIOIMPACT CAPITAL LLC | 0.85% | 2.07% | 740,661 | 299,402 | 67.85% | 13,339,305 | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 2.66% | 1.60% | 2,325,449 | -120,924 | -4.94% | 41,881,336 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.50% | 1.48% | 436,608 | 255,697 | 141.34% | 7,863,310 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 0.31% | 1.43% | 271,057 | 271,057 | 100.00% | 4,881,737 | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 0.66% | 1.39% | 574,517 | -79,136 | -12.11% | 10,347,051 | Jun 30, 2024 |
| BAKER BROS. ADVISORS LP | 6.67% | 1.34% | 5,840,059 | - | - | 105,179,463 | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 0.33% | 1.25% | 290,197 | -16,000 | -5.23% | 5,226,448 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3.28% | 0.86% | 2,874,586 | - | - | 51,771,294 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 2.12% | 0.79% | 1,856,417 | -463,229 | -19.97% | 33,434,070 | Jun 30, 2024 |
| ECOR1 CAPITAL, LLC | 1.43% | 0.69% | 1,250,385 | - | - | 22,519,434 | Jun 30, 2024 |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 0.81% | 0.51% | 710,723 | 102,711 | 16.89% | 12,800,121 | Jun 30, 2024 |
The largest Edgewise Therapeutics shareholder by % of total assets is NEW LEAF VENTURE PARTNERS, L.L.C.. The company owns 1.55M shares of Edgewise Therapeutics (EWTX), representing 34.03% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NOVO HOLDINGS A/S | 7.25% | 6.63% | 6,344,430 | 6,344,430 | 100.00% | 114,263,184 | Jun 30, 2024 |
| BELLEVUE GROUP AG | 1.63% | 0.42% | 1,428,929 | 1,428,929 | 100.00% | 25,735,011 | Jun 30, 2024 |
| BLACKROCK INC. | 6.87% | 0.00% | 6,015,711 | 848,705 | 16.43% | 108,342,955 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 2.98% | 0.03% | 2,607,299 | 801,987 | 44.42% | 46,928,267 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.31% | 0.01% | 1,145,506 | 613,251 | 115.22% | 20,630,563 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.60% | 0.02% | 528,594 | 528,594 | 100.00% | 9,519,978 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.15% | 0.00% | 4,508,166 | 490,733 | 12.22% | 81,192,069 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 0.54% | 0.45% | 475,691 | 475,691 | 100.00% | 8,567,195 | Jun 30, 2024 |
| STATE STREET CORP | 1.90% | 0.00% | 1,665,095 | 453,619 | 37.44% | 29,988,361,000 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 4.26% | 3.14% | 3,731,067 | 427,500 | 12.94% | 67,196,517 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.47% | 0.01% | 415,720 | 361,103 | 661.15% | 7,487,117 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.91% | 0.00% | 1,672,653 | 302,756 | 22.10% | 30,130,154 | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | 0.98% | 0.01% | 860,067 | 300,733 | 53.77% | 15,489,815 | Jun 30, 2024 |
| BIOIMPACT CAPITAL LLC | 0.85% | 2.07% | 740,661 | 299,402 | 67.85% | 13,339,305 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 0.31% | 1.43% | 271,057 | 271,057 | 100.00% | 4,881,737 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.31% | 0.03% | 268,143 | 268,143 | 100.00% | 4,829,000 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.50% | 1.48% | 436,608 | 255,697 | 141.34% | 7,863,310 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.31% | 0.00% | 272,794 | 219,031 | 407.40% | 4,913,020 | Jun 30, 2024 |
| POLAR ASSET MANAGEMENT PARTNERS INC. | 0.21% | 0.07% | 187,500 | 187,500 | 100.00% | 3,376,875 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 0.21% | 0.10% | 186,386 | 186,386 | 100.00% | 3,356,812 | Jun 30, 2024 |
As of Jun 30 2024, Edgewise Therapeutics's largest institutional buyer is NOVO HOLDINGS A/S. The company purchased 6.34M stocks of EWTX, valued at $114.26M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | 1.69% | 0.10% | 1,481,146 | -1,858,000 | -55.64% | 26,675,439 | Jun 30, 2024 |
| FMR LLC | 5.46% | 0.01% | 4,780,563 | -1,585,161 | -24.90% | 86,097,933 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 2.12% | 0.79% | 1,856,417 | -463,229 | -19.97% | 33,434,070 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.09% | 0.01% | 78,134 | -206,466 | -72.55% | 1,407,193 | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | - | - | - | -175,901 | -100.00% | - | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.36% | 0.01% | 311,476 | -162,204 | -34.24% | 5,609,682 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | - | - | - | -126,332 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.85% | 0.00% | 1,622,741 | -125,103 | -7.16% | 29,225,566 | Jun 30, 2024 |
| MORGAN STANLEY | 0.29% | 0.00% | 249,974 | -124,744 | -33.29% | 4,502,040 | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 2.66% | 1.60% | 2,325,449 | -120,924 | -4.94% | 41,881,336 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -103,208 | -100.00% | - | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.28% | 0.00% | 243,098 | -94,906 | -28.08% | 4,378,195 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 0.66% | 2.39% | 580,000 | -85,000 | -12.78% | 10,445,800 | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 0.66% | 1.39% | 574,517 | -79,136 | -12.11% | 10,347,051 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -74,511 | -100.00% | - | Jun 30, 2024 |
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | - | - | - | -60,881 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | 0.03% | 0.00% | 30,524 | -56,720 | -65.01% | 549,000 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -45,400 | -100.00% | - | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.03% | 0.00% | 29,846 | -38,852 | -56.55% | 538,000 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.41% | 0.01% | 362,576 | -30,159 | -7.68% | 6,529,994 | Jun 30, 2024 |
As of Jun 30 2024, Edgewise Therapeutics's biggest institutional seller is VIKING GLOBAL INVESTORS LP. The company sold -1.86M shares of EWTX, valued at $26.68M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BELLEVUE GROUP AG | 1.63% | 0.42% | 1,428,929 | 1,428,929 | 100.00% | 25,735,011 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.60% | 0.02% | 528,594 | 528,594 | 100.00% | 9,519,978 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 0.54% | 0.45% | 475,691 | 475,691 | 100.00% | 8,567,195 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 0.31% | 1.43% | 271,057 | 271,057 | 100.00% | 4,881,737 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.31% | 0.03% | 268,143 | 268,143 | 100.00% | 4,829,000 | Jun 30, 2024 |
| POLAR ASSET MANAGEMENT PARTNERS INC. | 0.21% | 0.07% | 187,500 | 187,500 | 100.00% | 3,376,875 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 0.06% | 0.00% | 49,597 | 49,597 | 100.00% | 893,242 | Jun 30, 2024 |
| FEDERATED HERMES, INC. | 0.05% | 0.00% | 46,234 | 46,234 | 100.00% | 832,674,000 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.05% | 0.00% | 44,783 | 44,783 | 100.00% | 806,542 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.04% | 0.00% | 39,054 | 39,054 | 100.00% | 703,363 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.03% | 0.00% | 29,286 | 29,286 | 100.00% | 527,441 | Jun 30, 2024 |
| TUDOR INVESTMENT CORP ET AL | 0.03% | 0.00% | 26,410 | 26,410 | 100.00% | 475,644 | Jun 30, 2024 |
| BLEAKLEY FINANCIAL GROUP, LLC | 0.02% | 0.01% | 15,265 | 15,265 | 100.00% | 274,923 | Jun 30, 2024 |
| SIMPLICITY WEALTH,LLC | 0.02% | 0.01% | 15,218 | 15,218 | 100.00% | 274,076 | Jun 30, 2024 |
| QUARRY LP | 0.02% | 0.07% | 14,000 | 14,000 | 100.00% | 252,140 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.02% | 0.04% | 13,908 | 13,908 | 100.00% | 250,483 | Jun 30, 2024 |
| STATE OF NEW JERSEY COMMON PENSION FUND D | 0.02% | 0.00% | 13,738 | 13,738 | 100.00% | 247,421 | Jun 30, 2024 |
| PROFUND ADVISORS LLC | 0.01% | 0.01% | 11,405 | 11,405 | 100.00% | 205,404 | Jun 30, 2024 |
| DARK FOREST CAPITAL MANAGEMENT LP | 0.01% | 0.04% | 10,699 | 10,699 | 100.00% | 192,689 | Jun 30, 2024 |
| ARIZONA STATE RETIREMENT SYSTEM | 0.01% | 0.00% | 10,459 | 10,459 | 100.00% | 188,367 | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | 0.01% | 0.04% | 5,054 | 5,054 | 100.00% | 91,023 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.00% | 0.00% | 3,070 | 3,070 | 100.00% | 55,290 | Jun 30, 2024 |
| MEEDER ASSET MANAGEMENT INC | 0.00% | 0.00% | 1,946 | 1,946 | 100.00% | 35,047 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.00% | - | 987 | 987 | 100.00% | 17,776 | Jun 30, 2024 |
| BFSG, LLC | 0.00% | 0.00% | 600 | 600 | 100.00% | 10,806 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | 0.00% | 98 | 98 | 100.00% | 1,765 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | 0.00% | 0.00% | 96 | 96 | 100.00% | 1,729 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | 0.00% | 0.00% | 76 | 76 | 100.00% | 1,330 | Jun 30, 2024 |
| J.SAFRA ASSET MANAGEMENT CORP | 0.00% | 0.00% | 64 | 64 | 100.00% | 1,153 | Jun 30, 2024 |
| NEWEDGE ADVISORS, LLC | - | - | 9 | 9 | 100.00% | 162 | Jun 30, 2024 |
| CREEKMUR ASSET MANAGEMENT LLC | - | - | 8 | 8 | 100.00% | 144 | Jun 30, 2024 |
Edgewise Therapeutics's largest new institutional shareholder by number of shares is BELLEVUE GROUP AG, purchased 1.43M shares, valued at $25.74M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | - | - | - | -175,901 | -100.00% | - | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | - | - | - | -126,332 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -103,208 | -100.00% | - | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -74,511 | -100.00% | - | Jun 30, 2024 |
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | - | - | - | -60,881 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -45,400 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -28,418 | -100.00% | - | Jun 30, 2024 |
| DENALI ADVISORS LLC | - | - | - | -19,200 | -100.00% | - | Jun 30, 2024 |
| CASTLEVIEW PARTNERS, LLC | - | - | - | -16,204 | -100.00% | - | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | - | - | - | -14,216 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -14,049 | -100.00% | - | Jun 30, 2024 |
| OXFORD ASSET MANAGEMENT LLP | - | - | - | -13,615 | -100.00% | - | Jun 30, 2024 |
| CORTON CAPITAL INC. | - | - | - | -13,042 | -100.00% | - | Jun 30, 2024 |
| ENTROPY TECHNOLOGIES, LP | - | - | - | -12,665 | -100.00% | - | Jun 30, 2024 |
| FOX RUN MANAGEMENT, L.L.C. | - | - | - | -10,814 | -100.00% | - | Jun 30, 2024 |
| QUANTBOT TECHNOLOGIES LP | - | - | - | -8,009 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -3,081 | -100.00% | - | Jun 30, 2024 |
| FINANCIAL SYNERGIES WEALTH ADVISORS, INC. | - | - | - | -111 | -100.00% | - | Jun 30, 2024 |
| COMERICA BANK | - | - | - | -57 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -8 | -100.00% | - | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | - | - | - | -4 | -100.00% | - | Jun 30, 2024 |
Edgewise Therapeutics's largest sold out institutional shareholder by shares sold is VOLORIDGE INVESTMENT MANAGEMENT, LLC, sold -0.18M shares, valued at -, as of undefined.
Edgewise Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| TEKLA LIFE SCIENCES INVESTORS | 0.32% | 150,418 | - | - | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.10% | 866,300 | 376,600 | 76.90% | Jan 31, 2024 |
| ALGER FUNDS | 0.08% | 72,572 | - | - | Jan 31, 2024 |
| AMERICAN CENTURY MUTUAL FUNDS, INC. | 0.07% | 675,135 | 221,455 | 48.81% | Jan 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.06% | 686,345 | 12,500 | 1.86% | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.06% | 30,691 | - | - | Mar 31, 2024 |
| FIDELITY SECURITIES FUND | 0.03% | 3,187,722 | 98,561 | 3.19% | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.03% | 70,000 | 70,000 | - | Mar 31, 2024 |
| Federated Hermes Equity Funds | 0.02% | 463,927 | - | - | Jan 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.02% | 1,381,885 | 728,100 | 111.37% | Feb 29, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.02% | 101,065 | 21,411 | 26.88% | Mar 31, 2024 |
| Vericimetry Funds | 0.02% | 1,420 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 8,482 | 1,851 | 27.91% | Mar 31, 2024 |
| FORUM FUNDS II | 0.01% | 13,974 | -5,104 | -26.75% | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 2,452 | 2,190 | 835.88% | Mar 31, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.01% | 88,505 | 56,918 | 180.19% | Mar 28, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 3,530,414 | 1,052,575 | 42.48% | Mar 31, 2024 |
| ETFis Series Trust I | 0.01% | 10,384 | - | - | Jan 31, 2024 |
| Destra Investment Trust | 0.01% | 9,754 | -2,466 | -20.18% | Mar 31, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.00% | 200,000 | 200,000 | - | Mar 31, 2024 |
| ALPS ETF Trust | 0.00% | 46,708 | 1,878 | 4.19% | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 116,673 | -3,978 | -3.30% | Jan 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 5,751 | 1,561 | 37.26% | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 426,014 | 36,869 | 9.47% | Feb 29, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 12,950 | - | - | Aug 31, 2023 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.00% | 40,000 | 40,000 | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 20,225 | 17,810 | 737.47% | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 49,752 | 17,465 | 54.09% | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES I | 0.00% | 249,300 | -87,300 | -25.94% | Feb 29, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 10,183 | -838 | -7.60% | Mar 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 45,976 | 45,199 | 5817.12% | Feb 29, 2024 |
| BNY MELLON FUNDS TRUST | 0.00% | 55,389 | - | - | Aug 31, 2023 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 3,400 | 3,400 | - | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 12,145 | -11,812 | -49.31% | Mar 31, 2024 |
| Managed Portfolio Series | 0.00% | 13,423 | - | - | Jan 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 18,296 | 111 | 0.61% | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 63,263 | 28,736 | 83.23% | Feb 29, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 2,619 | 673 | 34.58% | Mar 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 2,171 | - | - | Mar 31, 2024 |
| RBB FUND, INC. | 0.00% | 49,550 | 49,550 | - | Feb 29, 2024 |
| Dimensional ETF Trust | 0.00% | 198,039 | 153,301 | 342.66% | Jan 31, 2024 |
| AMERICAN CENTURY STRATEGIC ASSET ALLOCATIONS INC | 0.00% | 6,072 | 1,004 | 19.81% | Jan 31, 2024 |
| JANUS INVESTMENT FUND | 0.00% | 133,390 | - | - | Dec 31, 2023 |
| Global X Funds | 0.00% | 19,249 | 4,692 | 32.23% | Jan 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 220,576 | 7,568 | 3.55% | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 81,936 | -65,191 | -44.31% | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 20,841 | 7,000 | 50.57% | Mar 31, 2024 |
| Fidelity Rutland Square Trust II | 0.00% | 381,450 | 64,400 | 20.31% | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 8,045 | 6,745 | 518.85% | Mar 28, 2024 |
| Trust for Advised Portfolios | 0.00% | 4,835 | - | - | Dec 31, 2023 |
| TIAA-CREF LIFE FUNDS | 0.00% | 648 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 25,217 | 6,129 | 32.11% | Mar 28, 2024 |
| iSHARES TRUST | 0.00% | 2,779,077 | 867,501 | 45.38% | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 3,658 | 1,085 | 42.17% | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 31,885 | - | - | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 138,344 | 117,680 | 569.49% | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 149,566 | 33,554 | 28.92% | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 187,975 | 20,311 | 12.11% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 390 | - | - | Dec 31, 2023 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 8,310 | 8,310 | - | Mar 31, 2024 |
| SA FUNDS INVESTMENT TRUST | 0.00% | 1,162 | - | - | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 8,825 | 2,220 | 33.61% | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 59,024 | -69,091 | -53.93% | Jan 31, 2024 |
| VALIC Co I | 0.00% | 16,420 | -66 | -0.40% | Feb 29, 2024 |
| PROSHARES TRUST | 0.00% | 13,215 | 3,638 | 37.99% | Feb 29, 2024 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 11,160 | - | - | Feb 29, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 19,782 | 12,501 | 171.69% | Feb 29, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 194 | - | - | Dec 31, 2023 |
| TIAA-CREF FUNDS | 0.00% | 130,912 | - | - | Jan 31, 2024 |
| ProFunds | 0.00% | 448 | 88 | 24.44% | Mar 31, 2024 |
| Federated Hermes Global Allocation Fund | 0.00% | 362 | - | - | Feb 29, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 225 | - | - | Feb 29, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 4,547 | 463 | 11.34% | Jan 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 65,996 | 30,596 | 86.43% | Mar 31, 2024 |
| WILSHIRE MUTUAL FUNDS INC | 0.00% | 8,023 | -6 | -0.07% | Dec 31, 2023 |
| RYDEX VARIABLE TRUST | 0.00% | 26 | - | - | Dec 31, 2023 |
| Brighthouse Funds Trust II | 0.00% | 18,867 | 3,840 | 25.55% | Mar 31, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 61,045 | 51,489 | 538.81% | Dec 31, 2023 |
| TRUST FOR PROFESSIONAL MANAGERS | 0.00% | 6,503 | 6,503 | - | Feb 29, 2024 |
| Investment Managers Series Trust II | 0.00% | 253 | - | - | Mar 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 586 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,704 | - | - | Feb 29, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 4,847 | -20 | -0.41% | Jan 31, 2024 |
| ETF Series Solutions | 0.00% | 231 | - | - | Jan 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 42,714 | 10,030 | 30.69% | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 20,187 | 2,995 | 17.42% | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 2,482 | 1,377 | 124.62% | Feb 29, 2024 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 3,439 | - | - | Jan 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 23,188 | 5,830 | 33.59% | Mar 31, 2024 |
| Bridge Builder Trust | 0.00% | 23,364 | 5,380 | 29.92% | Mar 31, 2024 |
| GOLDMAN SACHS TRUST | 0.00% | 13,677 | - | - | Mar 31, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 400 | 300 | 300.00% | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 3,147 | - | - | Dec 31, 2023 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 6,945 | 1,307 | 23.18% | Mar 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 6,182 | -1,619 | -20.75% | Jan 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 5,379 | -641 | -10.65% | Jan 31, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 63 | - | - | Jan 31, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 8,300 | -3,370 | -28.88% | Feb 29, 2024 |
| FIDELITY SUMMER STREET TRUST | 0.00% | 111 | - | - | Jan 31, 2024 |
| John Hancock Funds II | 0.00% | 2,453 | 956 | 63.86% | Feb 29, 2024 |
Edgewise Therapeutics's largest mutual fund holder by % of total assets is "TEKLA LIFE SCIENCES INVESTORS", owning 150.42K shares, compromising 0.32% of its total assets.
Edgewise Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 42 | -67.44% |
| 31 Mar, 24 | 129 | 9.32% |
| 31 Dec, 23 | 118 | 37.21% |
| 30 Sep, 23 | 86 | -10.42% |
| 30 Jun, 23 | 96 | 10.34% |
| 31 Mar, 23 | 87 | -6.45% |
| 31 Dec, 22 | 93 | -2.11% |
| 30 Sep, 22 | 95 | 23.38% |
| 30 Jun, 22 | 77 | 8.45% |
| 31 Mar, 22 | 71 | 24.56% |
| 31 Dec, 21 | 57 | 21.28% |
| 30 Sep, 21 | 47 | 2.17% |
| 30 Jun, 21 | 46 | 48.39% |
| 31 Mar, 21 | 31 | - |
As of 30 Jun 24, 42 institutions are holding Edgewise Therapeutics's shares, representing a decrease of -67.44% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 4,895,731 | -94.66% |
| 31 Mar, 24 | 91,633,567 | 15.05% |
| 31 Dec, 23 | 79,648,503 | 16.42% |
| 30 Sep, 23 | 68,414,835 | -1.53% |
| 30 Jun, 23 | 69,476,308 | 4.55% |
| 31 Mar, 23 | 66,455,744 | -0.20% |
| 31 Dec, 22 | 66,590,213 | 3.43% |
| 30 Sep, 22 | 64,384,379 | 26.33% |
| 30 Jun, 22 | 50,965,887 | -5.56% |
| 31 Mar, 22 | 53,964,536 | 7.22% |
| 31 Dec, 21 | 50,332,800 | 4.78% |
| 30 Sep, 21 | 48,038,208 | 0.34% |
| 30 Jun, 21 | 47,877,195 | 4.81% |
| 31 Mar, 21 | 45,681,359 | - |
Edgewise Therapeutics (EWTX) has 4.90M shares outstanding as of 30 Jun 24, down -94.66% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 5.59% | 0.05% |
| 31 Mar, 24 | 104.64% | 0.67% |
| 31 Dec, 23 | 124.99% | 1.08% |
| 30 Sep, 23 | 107.81% | 0.90% |
| 30 Jun, 23 | 109.62% | 0.99% |
| 31 Mar, 23 | 105.04% | 0.95% |
| 31 Dec, 22 | 105.31% | 0.68% |
| 30 Sep, 22 | 124.19% | 1.18% |
| 30 Jun, 22 | 102.71% | 0.87% |
| 31 Mar, 22 | 108.92% | 1.04% |
| 31 Dec, 21 | 102.17% | 1.07% |
| 30 Sep, 21 | 97.51% | 1.03% |
| 30 Jun, 21 | 97.20% | 1.13% |
| 31 Mar, 21 | 92.82% | - |
As of 30 Jun 24, Edgewise Therapeutics is held by 5.59% institutional shareholders, representing a 0.05% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 28 | -68.89% |
| 31 Mar, 24 | 90 | 11.11% |
| 31 Dec, 23 | 81 | 65.31% |
| 30 Sep, 23 | 49 | -3.92% |
| 30 Jun, 23 | 51 | 34.21% |
| 31 Mar, 23 | 38 | -32.14% |
| 31 Dec, 22 | 56 | -5.08% |
| 30 Sep, 22 | 59 | 73.53% |
| 30 Jun, 22 | 34 | -19.05% |
| 31 Mar, 22 | 42 | - |
| 31 Dec, 21 | 42 | 82.61% |
| 30 Sep, 21 | 23 | -28.13% |
| 30 Jun, 21 | 32 | 3.23% |
| 31 Mar, 21 | 31 | - |
28 institutional shareholders have increased their position in EWTX stock as of 30 Jun 24 compared to 90 in the previous quarter (a -68.89% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 8 | -71.43% |
| 31 Mar, 24 | 28 | 40.00% |
| 31 Dec, 23 | 20 | 17.65% |
| 30 Sep, 23 | 17 | -26.09% |
| 30 Jun, 23 | 23 | -11.54% |
| 31 Mar, 23 | 26 | 62.50% |
| 31 Dec, 22 | 16 | -27.27% |
| 30 Sep, 22 | 22 | -21.43% |
| 30 Jun, 22 | 28 | 55.56% |
| 31 Mar, 22 | 18 | 500.00% |
| 31 Dec, 21 | 3 | -72.73% |
| 30 Sep, 21 | 11 | 83.33% |
| 30 Jun, 21 | 6 | - |
| 31 Mar, 21 | - | - |
8 institutional shareholders have reduced their position in EWTX stock as of 30 Jun 24 compared to 28 in the previous quarter (a -71.43% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 42 | -67.44% | 4,895,731 | -94.66% | 5.59% | 0.05% | 28 | -68.89% | 8 | -71.43% |
| 31 Mar, 24 | 129 | 9.32% | 91,633,567 | 15.05% | 104.64% | 0.67% | 90 | 11.11% | 28 | 40.00% |
| 31 Dec, 23 | 118 | 37.21% | 79,648,503 | 16.42% | 124.99% | 1.08% | 81 | 65.31% | 20 | 17.65% |
| 30 Sep, 23 | 86 | -10.42% | 68,414,835 | -1.53% | 107.81% | 0.90% | 49 | -3.92% | 17 | -26.09% |
| 30 Jun, 23 | 96 | 10.34% | 69,476,308 | 4.55% | 109.62% | 0.99% | 51 | 34.21% | 23 | -11.54% |
| 31 Mar, 23 | 87 | -6.45% | 66,455,744 | -0.20% | 105.04% | 0.95% | 38 | -32.14% | 26 | 62.50% |
| 31 Dec, 22 | 93 | -2.11% | 66,590,213 | 3.43% | 105.31% | 0.68% | 56 | -5.08% | 16 | -27.27% |
| 30 Sep, 22 | 95 | 23.38% | 64,384,379 | 26.33% | 124.19% | 1.18% | 59 | 73.53% | 22 | -21.43% |
| 30 Jun, 22 | 77 | 8.45% | 50,965,887 | -5.56% | 102.71% | 0.87% | 34 | -19.05% | 28 | 55.56% |
| 31 Mar, 22 | 71 | 24.56% | 53,964,536 | 7.22% | 108.92% | 1.04% | 42 | - | 18 | 500.00% |
| 31 Dec, 21 | 57 | 21.28% | 50,332,800 | 4.78% | 102.17% | 1.07% | 42 | 82.61% | 3 | -72.73% |
| 30 Sep, 21 | 47 | 2.17% | 48,038,208 | 0.34% | 97.51% | 1.03% | 23 | -28.13% | 11 | 83.33% |
| 30 Jun, 21 | 46 | 48.39% | 47,877,195 | 4.81% | 97.20% | 1.13% | 32 | 3.23% | 6 | - |
| 31 Mar, 21 | 31 | - | 45,681,359 | - | 92.82% | - | 31 | - | - | - |
Edgewise Therapeutics Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
All Insider Owners Trades
Edgewise Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 14 | - | - |
| Q2 2024 | 13 | 12 | 108.33% |
| Q1 2024 | 9 | 14 | 64.29% |
| Q4 2023 | 1 | 2 | 50.00% |
| Q3 2023 | 7 | - | - |
| Q2 2023 | 12 | 13 | 92.31% |
| Q1 2023 | 1 | - | - |
| Q4 2022 | 2 | 2 | 100.00% |
| Q3 2022 | 9 | 6 | 150.00% |
| Q2 2022 | 18 | 9 | 200.00% |
| Q1 2022 | 1 | 2 | 50.00% |
| Q4 2021 | 3 | 31 | 9.68% |
| Q3 2021 | 6 | 8 | 75.00% |
| Q2 2021 | 1 | - | - |
| Q1 2021 | 17 | 50 | 34.00% |
14 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Edgewise Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | - | - |
| Q2 2024 | - | 6 | - |
| Q1 2024 | 2 | 7 | 28.57% |
| Q4 2023 | 1 | 2 | 50.00% |
| Q3 2023 | - | - | - |
| Q2 2023 | - | 6 | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | 1 | - |
| Q3 2022 | 3 | 3 | 100.00% |
| Q2 2022 | 3 | 5 | 60.00% |
| Q1 2022 | - | - | - |
| Q4 2021 | - | 28 | - |
| Q3 2021 | - | 8 | - |
| Q2 2021 | - | - | - |
| Q1 2021 | 7 | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Edgewise Therapeutics's stocks.
Edgewise Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| TALS | Tourmaline Bio, Inc. |
| CGEM | Cullinan Oncology, Inc. |
| RVMD | Revolution Medicines, Inc. Warrant |
| DBTX | Decibel Therapeutics, Inc. |
| VOR | Vor Biopharma Inc. |
| IKNA | Ikena Oncology, Inc. |
| MLYS | Mineralys Therapeutics, Inc. |
| IPSC | Century Therapeutics, Inc. |
| BDTX | Black Diamond Therapeutics, Inc. |
| BCEL | Atreca, Inc. |
| PASG | Passage Bio, Inc. |
| CCCC | C4 Therapeutics, Inc. |
| DSGN | Design Therapeutics, Inc. |
| HOWL | Werewolf Therapeutics, Inc. |
| XLO | Xilio Therapeutics, Inc. |
| ACET | Adicet Bio, Inc. |
| CELC | Celcuity Inc. |
| ELYM | Eliem Therapeutics, Inc. |
EWTX Ownership FAQ
Who Owns Edgewise Therapeutics?
Edgewise Therapeutics is owned by institutional shareholders (5.59%), insiders (0.47%), and public (93.94%). The largest institutional shareholder of Edgewise Therapeutics is ORBIMED ADVISORS LLC (17.15% of total shares) and the top mutual fund owner is TEKLA LIFE SCIENCES INVESTORS (0.32% of total shares).
Who are the major institutional shareholders of Edgewise Therapeutics?
Edgewise Therapeutics's major institutional shareholders are ORBIMED ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., NOVO HOLDINGS A/S, BLACKROCK INC., and BAKER BROS. ADVISORS LP. The top five shareholders own together 48.11% of the company's share outstanding.
How many Edgewise Therapeutics shareholders are there?
As of Jun 2024, there are 42 institutional shareholders of Edgewise Therapeutics.
What percentage of Edgewise Therapeutics is owned by ORBIMED ADVISORS LLC?
ORBIMED ADVISORS LLC owns 15.02M shares of Edgewise Therapeutics, representing 17.15% of the company's total shares outstanding, valued at $270.54M (as of Jun 2024).
What percentage of Edgewise Therapeutics is owned by RA CAPITAL MANAGEMENT, L.P?
As of Jun 2024, RA CAPITAL MANAGEMENT, L.P holds 8.91M shares of Edgewise Therapeutics (EWTX), compromising 10.17% of the company, valued at $160.45M.
What percentage of Edgewise Therapeutics is owned by NOVO HOLDINGS A/S?
NOVO HOLDINGS A/S is the third largest holder of Edgewise Therapeutics. The company owns 6.34M of the company's shares outstanding (worth $114.26M).